Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug:224:28-29.
doi: 10.1016/j.imlet.2020.06.002. Epub 2020 Jun 6.

How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?

Malgorzata Kloc  1 , Rafik M Ghobrial  2 , Jacek Z Kubiak  3
Affiliations

How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?

Malgorzata Kloc et al. Immunol Lett. 2020 Aug.

Abstract

Statistical surveys of COVID-19 patients indicate, against all common logic, that people who smoke are less prone to the infection and/or exhibit less severe respiratory symptoms than non-smokers. This suggests that nicotine may have some preventive or modulatory effect on the inflammatory response in the lungs. Because it is known that the response to, and resolution of the SARS-CoV-2 infection depends mainly on the lung macrophages, we discuss the recent scientific findings, which may explain why and how nicotine may modulate lung macrophage response during COVID-19 infection.

Keywords: Acute respiratory distress syndrome - ARDS; COVID-19; Cytokine storm; Cytokines; Inflammation; Lungs; Macrophages; Nicotine; SARS-CoV-2; α4/α7 Nicotinic Ach receptors - nAChRs.

PubMed Disclaimer

References

    1. Lai C.-C.-C., Shih T.-P.-P., Ko W.-C.-C., Tang H.-J.-J., Hsueh P.-R.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;(Februry 17) doi: 10.1016/j.ijantimicag.2020.105924. [Epub ahead of print]. PMCID: PMC7127800. - DOI - PMC - PubMed
    1. Miyara M., Tubach F., Pourcher V., Morelot-Panzini C., Pernet J., Haroche J. Qeios; 2020. Low Incidence of Daily Active Tobacco Smoking in Patients With Symptomatic COVID-19. - DOI
    1. Lam D.C.-L., Kwok H.-H.-H., Yu W.-C., Ko F.W.-S., Tam C.-Y.-Y., Lau A.C.-W., Fong D.Y.-T., Ip M.S.-M. CC16 levels correlate with cigarette smoke exposure in bronchial epithelial cells and with lung function decline in smokers. BMC Pulm. Med. 2018;18:47. doi: 10.1186/s12890-018-0607-7. PMCID: PMC5857103. - DOI - PMC - PubMed
    1. Hu G., Christman J.W. Editorial: alveolar macrophages in lung inflammation and resolution. Front. Immunol. 2019;2019(24 September) doi: 10.3389/fimmu.2019.02275. - DOI - PMC - PubMed
    1. Joshi N., Walter J.M., Misharin A.V. Alveolar macrophages. Cell. Immunol. 2018;330:86–90. doi: 10.1016/j.cellimm.2018.01.005. - DOI - PubMed

MeSH terms